Rajesh Abraham

Elder Pharmaceuticals Ltd witnessed buying interest on market speculation that the company may hike its stake in the joint venture in Nepal. Elder Pharma has a 60:40 joint venture with Universal Group of Nepal. The shares closed at Rs 321.50, up from the previous close of Rs 316.25, on the BSE. On NSE, it gained 1.23 per cent at Rs 322.

Dealers said the new administration in Nepal is favourable to open up the market for overseas companies. This is likely to benefit Elder Pharmaceuticals, they said.

(This article was published in the Business Line print edition dated May 27, 2006)
XThese are links to The Hindu Business Line suggested by Outbrain, which may or may not be relevant to the other content on this page. You can read Outbrain's privacy and cookie policy here.